Goldman Sachs Group Inc Maravai Lifesciences Holdings, Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,612,841 shares of MRVI stock, worth $4.61 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,612,841
Previous 2,038,548
20.88%
Holding current value
$4.61 Million
Previous $16.9 Million
48.12%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding MRVI
# of Institutions
204Shares Held
138MCall Options Held
271KPut Options Held
37.6K-
Gtcr LLC20.2MShares$57.6 Million10.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$33.8 Million0.0% of portfolio
-
12 West Capital Management LP New York, NY11.6MShares$33.2 Million6.99% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$27.8 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$23.9 Million2.55% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $376M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...